Fig. 1From: Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65Adjusted odds of being tested was significantly higher for tested vs. untested women among women who did not initiate chemotherapy within six months of diagnosis. There were no significant differences in initiation by tested status in women had initiated chemotherapy within six months of diagnosisBack to article page